For­mer Alex­ion VP pleads guilty to in­sid­er trad­ing on Por­to­la buy­out

A for­mer Alex­ion ex­ec­u­tive con­fessed to in­sid­er trad­ing by shar­ing con­fi­den­tial com­pa­ny in­for­ma­tion in 2020 dur­ing a crim­i­nal hear­ing at a New York fed­er­al court on Sept. 15.

Joseph Dupont ad­mit­ted he had tipped off a friend about Alex­ion’s plan to buy Por­to­la Phar­ma­ceu­ti­cals in what he de­scribed as a “se­ri­ous er­ror in judg­ment,” as re­port­ed by Law360. Alex­ion was snapped up by phar­ma gi­ant As­traZeneca for $39 bil­lion in 2021.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER